
Innocare
A Chinese biopharmaceutical company that develops treatment for cancer and autoimmune diseases.
Market cap
$3.3b
Enterprise value
$2.5b
Share price
HKD13.10 9969.HK
Authorizing premium user...
A Chinese biopharmaceutical company that develops treatment for cancer and autoimmune diseases.